Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Endometrial Neoplasms 3Postoperative Complications 2Ovarian Neoplasms 2Lymphedema 2Lymphatic Metastasis 2Breast Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Platelet Glycoprotein IV Deficiency 1Parotid Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Facies 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Early Stage Endometrial Cancer 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 39Cisplatin 24Oxaliplatin 15pembrolizumab 12Capecitabine 12Fluorouracil 9Leucovorin 7Albumin-Bound Paclitaxel 7lenvatinib 6Radiofrequency Ablation 6Panitumumab 6130-nm albumin-bound paclitaxel 6Irinotecan 5Bevacizumab 5durvalumab 4Taxes 4Nivolumab 4Hepatectomy 4Drug Therapy 4tremelimumab 3apatinib 3Radiosurgery 3Platinum 3Injections 3Floxuridine 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3trametinib 2spartalizumab 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cholangiocarcinoma × Lymph Node Excision × Clear all
NCT03796819 2021-12-09

LND for ICC

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Completed
260 enrolled
Gastrointestinal

Lymphatic Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡